Biology Reference
In-Depth Information
Pontesilli O, Kerkhof-Garde S, Notermans DW, Foudraine NA, Roos MT, Klein MR, et al. 1999.
Functional T cell reconstitution and human immunode®ciency virus-1-speci®c cell-mediated
immunity during highly active antiretroviral therapy. J Infect Dis 180: 76±86.
Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, Ringuette N, Jenkins M,
McCune JM, Sekaly RP. 1999. Directe evidence for thymic function in adult humans. J Exp
Med 190: 479±486.
Renaud M, Katlama C, Mallet A, Calvez V, Carcelain G, Tubiana R, Jouan M, Caumes E, Agut
H, Bricaire F, Debre P, Autran B. 1999. Determinants of paradoxical CD4 cell reconstitution
after protease inhibitor containing antiretroviral regiment. AIDS 13: 669±676.
Rinaldo CR, Liebman JM, Huang XL, Fan Z, Shboul AI, McMahon DK, et al. 1999. Prolonged
suppression of human immunode®ciency virus type 1 (HIV-1) viremia in persons with advanced
disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1
antigens. J Infect Dis 179: 329±336.
Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. 1997.
Vigorous HIV-1 speci®c CD4 T cell responses associated with control of viremia. Science 278:
1447.
Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK,
D'Aquila RT, Goulder PJ, Walker BD. 2000. Immune control of HIV-1 after early treatment of
acute infection. Nature 407: 523±526.
Rosok BI, Bostad L, Voltersvik P, Olofsson J, AsjÈ B. 1996. Reduced CD4 cell counts in blood do
not re¯ect CD4 cell depletion in tonsilar tissue in asymptomatic HIV-1 infection. AIDS 10: 35±
38.
Saag MS. 1999. Limitations of antiretroviral therapy in HIV. Interscience Conference on Anti-
microbial Agents and Chemotherapy (ICAAC), San Francisco.
Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, Hirschel B, Perrin L. 1998. Turn-
over of CD4 and CD8 T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp
Med 187: 1295±1303.
Schneider MM, Borle¨s JC, Stolk RP, Jaspers CA, Hoepelman AI. 1999. Discontinuation of pro-
phylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly
active antiretroviral therapy. Lancet 353: 201±203.
Schooley RT. 1999. Long-term immunologic e¨ects and side e¨ects of successful antiretroviral
therapy. Clin Infect Dis 29: 12±18.
Schrager LK, D'Souza MP. 1998. Cellular and anatomical reservoirs of HIV-1 in patients receiving
potent antiretroviral combination therapy. JAMA 280: 67±71.
Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS. 1999. Human immuno-
de®ciency virus type 1 protease inhibitor modulates activation of peripheral blood CD4()
T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94: 1021±
1027.
Smith KY, Valdez H, Landay A, Spritzler J, Gross BH, Francis IR, Kessler HA, Connick E,
McCune JM, Lederman MM. 2000. Thymic size and lymphocyte restoration in HIV infected
patients following 48 weeks of therapy with zidovudine, lamivudine and ritonavir. J Infect Dis
181: 141±147.
Sprent J, Tough DF. 1994. Lymphocyte life-span and memory. Science 265: 1395±1400.
Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdor¨ B, Grosschup¨
G, Steinman RM, Racz P. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic
patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation.
The impact of highly active antiretroviral therapy. J Exp Med 187: 949±959.
Tissot O, Viard JP, Rabian C, Ngo N, Burgard M, Rouzioux C, Penit C. 1998. No evidence for
proliferation in the blood CD4 T cell pool during HIV-1 infection and triple combination
therapy. AIDS 12: 879±884.
Search WWH ::




Custom Search